Mercury Laboratories Ltd.
Fundamentals
- Market cap
- ₹97.56 cr
- P/E
- 20.19×
- ROE
- 5.87%
- Debt / equity
- 0.08
- Div yield
- 0.43%
- 52-week range
- 620.55 — 976.00
Company snapshot
Mercury Laboratories Ltd.
Pharmaceuticals
₹100 cr
P/E 24.07×
Latest quarter · Jun 2026
Sales₹16 cr
Net profit₹0 cr
Op. margin+7.5%
EPS₹2.48
Strength & growth
Debt / equity0.08×
Current ratio2.66×
Sales CAGR+4.5%
EPS CAGR+1.8%
The timeline — 2 notes on Mercury Laboratories Ltd.
July 2026
- 25 Jul 26 · 12:39 PM IST Brief Brief · Earnings · Micro cap
Mercury Labs net profit plunges 69% as revenue slips in Q1
Pharma nano-cap posts ₹29.78 lakh profit vs ₹96.76 lakh a year ago; revenue down 12% to ₹15.96 crore.
- 25 Jul 26 · 12:17 PM IST Brief Brief · Earnings · Micro cap
Mercury Labs profit dives 69% in Q1 as revenue slips 12%
Net profit plunges to ₹29.78 lakh from ₹96.76 lakh a year ago; auditors issue unmodified report.